Travere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.

However, the reduction in AER observed after 2 months with irbesartan treatment is in accordance with the findings shown in the IRMA II after 3 months of therapy ( 30% for both studies), proving ...

Find all the commercial and brand names of generic drug called Irbesartan. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Travere Therapeutics reached an agreement Tuesday on what data the FDA would require to approve its drug for a kidney disease.